First Time Loading...

Centogene NV
NASDAQ:CNTG

Watchlist Manager
Centogene NV Logo
Centogene NV
NASDAQ:CNTG
Watchlist
Price: 0.4889 USD 1.88% Market Closed
Updated: Apr 28, 2024

Centogene NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Centogene NV
Revenue Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Centogene NV
NASDAQ:CNTG
Revenue
€47.5m
CAGR 3-Years
-1%
CAGR 5-Years
8%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Revenue
€3.8B
CAGR 3-Years
99%
CAGR 5-Years
97%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Revenue
€238.3m
CAGR 3-Years
-10%
CAGR 5-Years
26%
CAGR 10-Years
12%
Immatics NV
NASDAQ:IMTX
Revenue
€54m
CAGR 3-Years
20%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Revenue
€684.6m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
3%
Formycon AG
XETRA:FYB
Revenue
€42.5m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Centogene NV's Revenue?
Revenue
47.5m EUR

Based on the financial report for Dec 31, 2022, Centogene NV's Revenue amounts to 47.5m EUR.

What is Centogene NV's Revenue growth rate?
Revenue CAGR 5Y
8%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Centogene NV have been -1% over the past three years , 8% over the past five years .